Evidence map›Paper›PMID 32381147›Full record

ArticleInfection control and hospital epidemiology2020

Respiratory surveillance wards as a strategy to reduce nosocomial transmission of COVID-19 through early detection: The experience of a tertiary-care hospital in Singapore.

Liang En Wee, Jenny Yi Chen Hsieh, Ghee Chee Phua, Yuyang Tan, Edwin Philip Conceicao, Limin Wijaya, Thuan Tong Tan, Ban Hock Tan

Registry-linked trialAbstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04894409 (Evaluation of Silver Nanoparticles as an Oropharyngeal Product), which is not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04894409 nacompletednot on this map

Evaluation of Silver Nanoparticles as an Oropharyngeal Product (Mouthwash) and Nasal Hygiene, by Health Personnel Working at the Tijuana General Hospital Exposed to Patients Diagnosed With Atypical Pneumonia Caused by SARS-CoV-2

TypeinterventionalSponsorCluster de Bioeconomia de Baja California, A.CRan2020 to 2020Enrolled231ConditionsCoronavirus Disease 2019 (COVID-19)ArmsMouthwash and nose rinse with the AgNPs solution, Mouthwashes and nose rinse in a conventional way
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. No Change ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liang En WeeSinghealth Infectious Diseases Residency, Singapore.ORCID https://orcid.org/0000-0001-6428-9999
Jenny Yi Chen HsiehDepartment of Internal Medicine, Singapore General Hospital, Singapore.
Ghee Chee PhuaDepartment of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.
Yuyang TanDepartment of Internal Medicine, Singapore General Hospital, Singapore.
Edwin Philip ConceicaoDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Limin WijayaDepartment of Infectious Diseases, Singapore General Hospital, Singapore.
Thuan Tong TanDepartment of Infectious Diseases, Singapore General Hospital, Singapore.
Ban Hock TanDepartment of Infectious Diseases, Singapore General Hospital, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPatients with COVID-19 may present with respiratory syndromes indistinguishable from those caused by common viruses. Early isolation and containment is challenging. Although screening all patients with respiratory symptoms for COVID-19 has been recommended, the practicality of such an effort has yet to be assessed.

methodsOver a 6-week period during a SARS-CoV-2 outbreak, our institution introduced a "respiratory surveillance ward" (RSW) to segregate all patients with respiratory symptoms in designated areas, where appropriate personal protective equipment (PPE) could be utilized until SARS-CoV-2 testing was done. Patients could be transferred when SARS-CoV-2 tests were negative on 2 consecutive occasions, 24 hours apart.

resultsOver the study period, 1,178 patients were admitted to the RSWs. The mean length-of-stay (LOS) was 1.89 days (SD, 1.23). Among confirmed cases of pneumonia admitted to the RSW, 5 of 310 patients (1.61%) tested positive for SARS-CoV-2. This finding was comparable to the pickup rate from our isolation ward. In total, 126 HCWs were potentially exposed to these cases; however, only 3 (2.38%) required quarantine because most used appropriate PPE. In addition, 13 inpatients overlapped with the index cases during their stay in the RSW; of these 13 exposed inpatients, 1 patient subsequently developed COVID-19 after exposure. No patient-HCW transmission was detected despite intensive surveillance.

conclusionsOur institution successfully utilized the strategy of an RSW over a 6-week period to contain a cluster of COVID-19 cases and to prevent patient-HCW transmission. However, this method was resource-intensive in terms of testing and bed capacity.

Indexed as

Patient IsolationAdultAgedAged, 80 and overBetacoronavirusCoronavirus InfectionsCOVID-19Cross InfectionEarly DiagnosisFemaleHumansInfection ControlInfectious Disease Transmission, Patient-to-ProfessionalLength of StayMaleMiddle Aged

Identifiers

PMID32381147
PMCPMC7248590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.